BRIEF published on 09/11/2024 at 07:35, 5 days 13 hours ago Medincell establishes a new liquidity contract with Rothschild Martin Maurel Common Shares Euronext Paris Liquidity Contract Rothschild Martin Maurel Medincell
BRIEF published on 09/11/2024 at 07:35, 5 days 13 hours ago Medincell établit un nouveau contrat de liquidité avec Rothschild Martin Maurel Euronext Paris Contrat De Liquidité Rothschild Martin Maurel Actions Ordinaires Medincell
PRESS RELEASE published on 09/11/2024 at 07:30, 5 days 13 hours ago Acquisition or disposal of the issuer's own shares / Information relating to the liquidity contract Medincell appoints ROTHSCHILD MARTIN MAUREL for liquidity contract management on Euronext Paris, complying with AMF Decision 2021-01 Euronext Paris Liquidity Contract Rothschild Martin Maurel AMF Decision Medincell
PRESS RELEASE published on 09/11/2024 at 07:30, 5 days 13 hours ago Acquisition ou cession des actions de l'émetteur / Information relative au contrat de liquidité Medincell confie son Contrat de liquidité à ROTHSCHILD MARTIN MAUREL pour animer ses actions sur Euronext Paris, conformément à la réglementation en vigueur Euronext Paris Contrat De Liquidité Rothschild Martin Maurel Réglementation Medincell
BRIEF published on 09/05/2024 at 07:35, 11 days 13 hours ago Medincell: Promising advances for injectable Olanzapine Schizophrenia Phase 3 Medincell Olanzapine Teva Pharmaceuticals
BRIEF published on 09/05/2024 at 07:35, 11 days 13 hours ago Medincell : avancées prometteuses pour l'Olanzapine injectable Schizophrénie Phase 3 Medincell Olanzapine Teva Pharmaceuticals
PRESS RELEASE published on 09/05/2024 at 07:30, 11 days 13 hours ago Informations privilégiées / Autres communiqués Teva, partenaire de Medincell, annonce des avancées importantes dans l'essai clinique pivot de phase 3 de l'Olanzapine injectable à durée d’action prolongée, avec un taux élevé d'injections réalisées et des résultats positifs attendus Schizophrénie Essai Clinique Medincell Olanzapine Teva
PRESS RELEASE published on 09/05/2024 at 07:30, 11 days 13 hours ago Inside Information / Other news releases Teva provides update on pivotal Phase 3 of Olanzapine LAI by Medincell. Safety results on track for H2 2024. Potential innovative long-acting antipsychotic treatment Clinical Trials Phase 3 Medincell Teva Olanzapine LAI
BRIEF published on 08/20/2024 at 17:52, 27 days 2 hours ago Modalités de participation à l’Assemblée Générale de Medincell Actionnaires Assemblée Générale Vote À Distance Medincell Videoconference
BRIEF published on 08/20/2024 at 17:52, 27 days 2 hours ago Terms of participation in the Medincell General Meeting Shareholders General Assembly Remote Voting Medincell Videoconference
Published on 09/16/2024 at 20:15, 35 minutes ago New to the Street's Episode 601 Will Air as Sponsored Programming on Fox Business at 10:30 PM PST, September 16, 2024. This Special Episode Will Feature In-Depth Interviews and Profiles of Industry-Leading Companies Driving Innovation in Their Respective
Published on 09/16/2024 at 20:07, 43 minutes ago Nexera Provides Update#2 on Delayed Filing of Annual Financial Statements and MD&A and Management Cease Trade Order
Published on 09/16/2024 at 20:00, 50 minutes ago Lender Market Unveils AI-Powered Financial Advisor Service for Business Owners
Published on 09/16/2024 at 19:30, 1 hour 20 minutes ago Gabriel Resources Ltd. - Resignation of Director
Published on 09/16/2024 at 19:30, 1 hour 20 minutes ago Gamehost Announces Regular Monthly Dividend for September
Published on 09/16/2024 at 18:32, 2 hours 17 minutes ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 09/16/2024 at 18:19, 2 hours 30 minutes ago BILENDI: Bilendi dévoile 2 projets basés sur son intelligence artificielle générative BARI présentés au congrès mondial ESOMAR
Published on 09/16/2024 at 17:59, 2 hours 50 minutes ago EQS-Adhoc: Airbus reports share buyback transactions 9-13 September 2024
Published on 09/16/2024 at 16:16, 4 hours 34 minutes ago Original-Research: Netfonds AG (von Montega AG): Kaufen
Published on 09/16/2024 at 15:28, 5 hours 21 minutes ago Form 8.3 - The Vanguard Group, Inc.: International Paper Company
Published on 09/16/2024 at 18:00, 2 hours 50 minutes ago Report on the Combined General Meeting of the 12th of September 2024
Published on 09/16/2024 at 18:00, 2 hours 50 minutes ago Compte-rendu d’Assemblée Générale Mixte du 12 septembre 2024
Published on 09/16/2024 at 18:00, 2 hours 50 minutes ago Programme de rachat d’actions propres : Déclaration des transactions sur actions propres réalisées du 9 septembre 2024 au 13 septembre 2024
Published on 09/16/2024 at 18:00, 2 hours 50 minutes ago Share buy-back program: Disclosure of trading in own shares from 9 September 2024 to 13 September 2024
Published on 09/16/2024 at 18:00, 2 hours 50 minutes ago imerys-16-09-2024-communique-capital-droits-de-vote-au-31-juillet-2024